ONCOCYTE CORP (OCX) Institutional Ownership and Insiders Activity

ONCOCYTE CORP (OCX) is widely held by institutional investors, with 38 firms reporting positions valued at approximately $108.91M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Broadwood Capital Inc is the largest disclosed holder, reporting approximately $74.84M in OCX holdings in its latest filing.

Institutional ownership remains highly concentrated, with Broadwood Capital Inc representing the majority of disclosed value.